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EARLY POSTPARTUM HORMONAL THERAPY
IMPROVES FERTILITY OF DAIR Y COWS l
J. S. Stevenson and M. BenMrad
Summary
1
A study of 234 Holste in cows was conducted to determine if hormonal
treatments of gonadotropin-releasing hormone (GnRH or Cystorelin®) and(or)
prostaglandin F a (PGF or Lutalyse®) given early after calving would improve
subsequent fertdity of dairy cows. Treatment of cows having abnormal conditions
associated with calving (puerperal problems) reduced inter val from calving to
conception by 43 to 48 days when GnRH was given once between days 10 and 14
postpartum or when PGF was administered once between 20 and 24 days after
calving compared with cows given only saline (controls). The reduction in days
open was 27 to 29 days overall for all cows (normal and abnormal) treated with
either hormone compared with controls. Cows (normal and abnormal) given either
hormone required 26 to 41 % fewer inseminations per conception than controls.
Reasons for improved fertility are discussed. We conclude that early postpartum .-
treatments with GnRH or PGF improved fertility of dair y cows, especially those •
that experienced puerperal problems.
In troduct ion
Initiating early reestablishment of est;ous cycles after calving is essential for
allowing adequate time for cows to be inseminated and maintain a yearly calving
interval. Normally, intervals from parturition to first ovulation average about 3 wk.
Because not all first ovulations are preceded by estrus, interval to first heat
averages about 5 to 6 wk. Both intervals are delayed in cows with periparturient
problems such as calving problems, uterine infections, ovarian cysts, injury, or
metabolic diseases (ketosis, displaced abomasum, etc.). Gonadotropin-releasing
hormone (GnRH or Cystorelin®) is effective for treating ovarian follicular cysts,
enhancing uterine involution, and inducing ovulation of ovarian follicles early
postpartum. Another hormone, prostaglandin F 20. (PGF), is luteolytic or capable of
regressing the corpus luteum and br inging the cow into heat in 2 to 5 days after
treatment. PGF has been used effectively to treat ovarian luteal cysts and cows
with pyometra or endometritis (if there was a corpus luteum present on the ovary).
The objective of our study was to determine if treatments of GnRH and(or) PGF
could improve fertility by altering the frequency and occurrence of early
postpartum estrus and ovulation.
lWe gratefully acknowledge Dr. M. D. Brown and CEVA Laboratories,
Overland Park, KS for their donatioll of Cystorelin® and J. F. McAlJister and The .)
Upjohn Company, Kalamazoo, MI for their gift of Lutalyse® used in this study. ~
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Procedures
This study utilized 234 Holstein cows in the KSU dairy herd) which calved
between July 1, 1982 and June 30, 1983. Cows were allotted randomly at calving
to one of four experimental groups (Table 1).
Table 1. Assignment of cows to treatment groupsa
Group
Item
Treatment
Gn RH (200 IJg)
PGF (25 mg)
No. cows
GnRH
days 10-14
59
2
PGF
days 20-24
59
3 4
GnRH-PGF Saline
days 10-14
days 20-24
57 59
a Days after calving when one intramuscular dose was given.
Cows were examined at calving and between 25 and 40 days postpartum for
various abnormalities. Observations at both times determined whether a cow was
classified as having a normal or abnormal puerperium. Abnormal classification
included any cow that had dystocia, retained placenta, uterine infections, milk
fever, ketosis, or unusual enlargement of the uterine horns or cervix.
Blood was collected thrice weekly to monitor blood serum concentrations of
progesterone. This allowed us to know when ovula t ions occurred and when a corpus
luteum was present. Intervals to estrus, inseminations, and conception were
determined as well as average number of services per conception.
Results and Discussion
Reproductive traits were improved for cows treated with either GnRH or PGF
(Table 2).
Cows given GnRH or PGF conceived ear lier after cal ving with fewer services,
and tended to have higher conception rates at first service than control cows
treated with saline alone. Responses after both hormones were intermediate for
the most part,except for reducing services per conception.
An additional benefit of these treatments was the positive effects on cows
with an abnormal puerperium. Nearly 30% of the cows had one or more postpartum
abnormalities including dystocia, retained placenta, uterine infection, purulent
discharge, milk fever, ketosis, or abnormal enlargement of the uterine horns or
cervix. At least 77% of the abnormalities observed were of reproductive origin. In
all cases, treatment of these cows with GnRH or PGF improved subsequent
reproductive performance.
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Table 2. Reproductive measures of cows after treatment
Item GnRH PGF GnRH-PGF Control
First service conception, % 40 42 38 29
Normal cows 42 48 44 35
Abnormal cows 31 21 29 13
Days from calving to conception 88* 86* 96 115
Normal cows 92 83 82 97
Abnormal cows 85* 90* 109 133
Services per conception 1.7* 1.8* 2.1 2.3
Normal cows 1.7* 1.6* 1.7* 2.2
Abnormal cows 1.7* 1.9* 2.4* 2.4
*Significant improvement compared with control cows (P<.05 ).
Examining various other measurements revealed possible explanations for the
improvements in fertility. Gn RH treatment reduced intervals to when cows first
ovulated and came into estrus after calving, as well as increasing the proportion of
cows with three or more ovula tions before first service from 54% for controls to
83%. Treatment with PGF reduced intervals to second and third ovulations and
shortened the duration of the first estrous cycle. Both treatments increased the
proportion of cows with estrous cycles of normal duration (18-24 days) before 6 wk
postpartum. Therefore, improvement of fertility was associated with increased
frequency and occurrence of ovula tion and estrus before first services and the
re-establishment of estrous cycles of normal duration. Our work suggests that all
cows, especially those with an abnormal pueriperium, had improved fertility when
treatment early postpartum with GnRH or PGF.
At present we do not know if such treatments are repeatable in aU dairy
herds or if they are economical. We are conduct ing further studies in other herds
to verify our present findings. Based on our initial work, it would appear that such
treatments (GnRH on days 10,11,12, 13,or 14 or PGF on days 20,21,22,23, or
24) are of economic value for cows that experience postpartum abnormalities
because treatments result in improved reproductive performance.
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